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Introduction to pharmacodynamics
Abstract
In this second article in the series of ‘bite sized’ pharmacology we will start to look at the principles 
of pharmacodynamics. It is important that prescribers are aware of the actions their drugs have in the 
body after administration. They should know the SITE of action (where the drug works), the MODE 
of action (how the drug works) and the time to ONSET and DURATION of action (when the drug 
starts to work and how long for). This helps prescribers decide on drug choice, drug dose and the dose
schedule as well as the length of time the drug needs to be prescribed for. This knowledge can also 
assist the prescriber in prediction and prevention (or minimising) of adverse drug reactions and to help
educate their patients on possible side effects. In this article we will look at SITEs of action; receptors,
ion channels, enzymes, and transport systems.  We will also introduce the concepts of agonism and 
antagonism and their relationship to MODE of action.
Pharmacology is the study of drugs (chemicals) and their interactions with the body.
The word pharmacology is derived from the Greek word pharmakon which can mean both remedy 
and poison. There are two ways we can study the interactions of drugs with the body, those being 
pharmacokinetics and pharmacodynamics. 
Pharmacodynamics can be defined in its simplest terms as the effect(s) that the drug has on the body. 
These can be categorised into 3 areas
 Desired effects- the reason we take the drug in the first place
 Side effects- effects that can be cause by the drug and are often known about and may be 
desired or unwanted
 Adverse effects- effects that can be cause by the drug but are usually unknown and always 
unwanted
Drugs can act at a variety of different sites in the body that we call molecular (chemical) targets. The 
main sites of action that can be identified as chemical drug targets are outline as follows.
Receptors
Many commonly used drugs act at receptors and most of you reading this will be familiar with the 
name. Receptors are found in virtually all cells within the body. Examples include;
1. Ionotropic receptors (also known as ligand gated ion channels) such as the GABAA receptor, 
which respond to the class of drugs known as benzodiazepines.
2. G-protein coupled receptors such as adrenoceptors.
3. Kinase linked receptors such as the insulin receptor.
4. Nuclear receptors such as the thyroid receptor.
Figure 1. Drug A Binding at a cellular receptor
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Ion Channels
Drug action at ion channels can take two forms (see Figure 2)
1. Channel blockers
The drug blocks permeation of the channel by sitting in it and prevention passage of other
ions and chemicals.
2. Channel modulators
The drug binds to a receptor site within the ion channel and modulates permeation. This 
can happen by the drug altering the channels response to its normal mediator or by changing 
the shape of the channel.
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Figure 2. Drug Binding at Ion Channels
In a. A drug molecule blocking the actual ion channel itself
In b. A drug molecule binding to the channel but not sitting within the channel itself.
Enzymes
Enzymes are biological catalysts that increase the rate of chemical reactions in the body. 
They are part of many normal physiological functions and reactions without which the body 
could not function as efficiently. Many drugs target enzymes to prevent them from carrying 
out their normal function.  For example, the drug ramipril acts on angiotensin converting 
enzyme (ACE), to prevent its conversion from angiotensin I to angiotensin II (Figure 3).  
This action (inhibition) of ACE leads to a reduction in blood pressure.
Figure 3- ACE action on angiotensin 1
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Transport Systems
These are distinct from plasma transport and are located on cells in many areas of the body. 
These are also known as carrier molecule interactions. In some neurotransmitter systems, 
there is normal physiological reuptake of the transmitters after release from a neurone into the
synapse. The transmitter serotonin is an example of this reuptake. After serotonin is released 
from a neurone into the synaptic space, it is taken back up by that same neurone using a 
serotonin selective reuptake (SSR) system.  A drug belonging to the class of SSRI (selective 
serotonin reuptake inhibitors) such as citalopram has its action at this transport system. It acts
to block the uptake transporter. This means that serotonin molecules are in the synapse longer
and results in an increased level of serotonergic activity. This mechanism has an onward 
effect which increases mood and makes these good antidepressant drugs (see Figure 4). 
Figure 4 Transport System Interaction
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Exercise
Using available pharmacological resources such as a pharmacology textbook, the BNF or the online 
electronic medicines compendium, find out the SITE of action of a drug from your area of practice. 
The Concept of Affinity 
Drugs have what we call affinity for their receptors, or chemical targets. This tells us how well a drug 
can bind to its target. Some chemicals and drug molecules have a higher affinity for their targets than 
others. Drugs possessing high affinity will bind in preference to other drug molecules available. 
Sometimes a drug molecule has a higher affinity for the targets than the normal endogenous mediator 
for that target. This can be therapeutically useful, especially where the endogenous agonist is 
abundant and may be causing the problem or symptom the patient is experiencing. Higher affinity 
means that even small amounts of the drug will bind preferentially. A good example is that 
antihistamines such as chlorphenamine have a good affinity for the histamine receptor over its 
endogenous agonist histamine and are useful in treating allergic responses.
Agonistic and Antagonistic Drug Action
Drugs can either be described as agonists or antagonists at their target sites. This is best explained 
using receptors as an example of a target site (see Figure 5).
 Agonists: these are drugs that bind to their targets and form a drug-receptor complex. The 
agonists activate the receptors to produce a response. 
 Antagonists: these are drugs that bind to their targets and form a drug receptor complex, but 
without causing activation or response. They can block the receptor to its endogenous 
activator, thereby blocking normal function. 
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Figure 5. Basic Receptor Theory
Exercise
Using available pharmacological resources such as a pharmacology textbook, the BNF or the online 
electronic medicines compendium, find out the MODE of action of a drug from your area of practice, 
HOW does it exert its effect? 
This has been a brief introduction to the concepts of pharmacodynamic actions. In future 
articles in this series we will explore aspects of pharmacodynamic actions in more detail, 
looking at drug onset and duration of action 
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